Ketamine is used to treat depression, anxiety, PTSD, OCD, and certain chronic pain syndromes—especially in patients who haven’t responded to traditional treatments.

Ketamine works by modulating glutamate, a neurotransmitter in the brain. It is thought to promote neuroplasticity, which may support improvements in mood and cognition.

When administered by trained clinicians in a controlled environment under continuous monitoring, ketamine is generally well-tolerated. Individual responses and risks vary, and we follow strict monitoring protocols during and after each session.

A standard protocol includes six infusions over two to three weeks (the “acute series”), followed by maintenance infusions based on individual response.

Yes, though most patients feel relaxed, dissociated, or experience changes in perception during the session. You are monitored continuously.

No. Patients must have a responsible adult accompany them and drive them home. You cannot operate a vehicle for the remainder of the day following your infusion.